Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00816283
Recruitment Status : Completed
First Posted : January 1, 2009
Last Update Posted : July 17, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011